(Q38821395)

6 September 2017

title

Metabolic Liver Disease: When to Suspect and How to Diagnose? (English)

1 reference

6 September 2017

Seema Alam

1

1 reference

6 September 2017

Vikrant Sood

series ordinal

2

1 reference

6 September 2017

publication date

29 April 2016

1 reference

Indian Journal of Pediatrics

6 September 2017

published in

1 reference

6 September 2017

volume

83

1 reference

6 September 2017

issue

11

1 reference

6 September 2017

page(s)

1321-1333

1 reference

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Etiology and prognosis of acute liver failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Alpha 1 antitrypsin deficiency in children with chronic liver disease in North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Acute Liver Failure in Infants and Young Children in a Specialized Pediatric Liver Centre in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Fructose-1,6-bisphosphatase deficiency: a case of a successful pregnancy by closely monitoring metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Etiology and prognostic factors of acute liver failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Characterization and outcomes of young infants with acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Liver transplantation for pediatric metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Long-term outcome following pediatric liver transplantation for metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Significant hepatic involvement in patients with ornithine transcarbamylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Two cases of hereditary fructose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

EASL Clinical Practice Guidelines: Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Treatment of inherited metabolic disorders by liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Gene therapy for inherited diseases of liver metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-016-2097-Z

Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.

21 January 2018

1 reference

12 December 2020

Successful liver transplantation and long-term follow-up in a patient with MPI-CDG

1 reference

12 December 2020

Liver failure associated with mitochondrial DNA depletion

1 reference

12 December 2020

Glycogen storage disease: report of 17 cases from southern India

1 reference

12 December 2020

Alpha-1 antitrypsin deficiency among Indian children with liver disorders

1 reference

12 December 2020

Current spectrum of hepatobiliary disorders in northern India

1 reference

12 December 2020

Mutational analysis of the galactose-1-phosphate uridyltransferase (GALT) gene in southeast part of Turkey: a regional report.

1 reference

12 December 2020

Current status of hepatocyte transplantation

1 reference

12 December 2020

Galactosemia presenting as recurrent sepsis

1 reference

12 December 2020

Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy

1 reference

12 December 2020

Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)

1 reference

12 December 2020

Acute liver failure in under two year-olds--are there markers of metabolic disease on admission?

1 reference

12 December 2020

10.1007/S12098-016-2097-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1010989801

0 references

1 reference